Kentucky launches probe into drug overcharges by pharmacy benefit managers

22 March 2019 - Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that ...

Read more →

Mystery solved: the pharma-backed group with a lot to say on Trump’s pitch to end drug rebates

20 March 2019 - RetireSafe, a Washington-based advocacy group with ties to the drug industry, appears to be behind a ...

Read more →

A drug pricing mystery: Who’s behind all the outrage over rebates?

19 March 2019 - The Department of Health and Human Services has already received 18,000 comments on its proposal to end ...

Read more →

Drug price watchdog ICER dives into Trump fueled pharma rebate debate

13 March 2019 - With public and political winds blowing in the same direction, significant reform of the complicated U.S. ...

Read more →

UnitedHealth expands drug rebate program to consumers

12 March 2019 - UnitedHealth, the country’s largest health insurer, said Tuesday it would expand a program that passes drug ...

Read more →

Institute for Clinical and Economic Review publishes white paper on alternative models for pharmaceutical rebates

12 March 2019 - Paper explores how reforming or eliminating rebates may affect drug pricing, patient access, and incentives for future ...

Read more →

Gottlieb: drug rebates not benefiting sicker patients

6 March 2019 - Food and Drug Administration (FDA) Commissioner Scott Gottlieb said Wednesday that drug discounts known as rebates ...

Read more →

Prescription drugs—list price, net price, and the rebate caught in the middle

6 March 2019 - Pharmacy benefit managers, such as Express Scripts, CVS Caremark, and Optum Rx, are some of the ...

Read more →

Regulatory information – adjusted fees for applications to EMA from 1 April 2019

1 March 2019 - The EMA reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for ...

Read more →

Rebates and drug costs: what the new proposal would mean

28 February 2019 - The Trump administration is trying in myriad ways to answer demands from consumers for lower prescription ...

Read more →

A small drug maker settles charges for paying others to submit its FDA applications

26 February 2019 - A small drug maker was fined $4 million for striking deals with two tiny companies to ...

Read more →

Prescriptions to rise to £9 from April

25 February 2019 - The government has announced another rise in prescription costs for medicines dispensed on the NHS in ...

Read more →

Novartis CEO lauds Trump administration plan to overhaul rebates

7 February 2019 - Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to ...

Read more →

More affordable medicines for all Australians

 6 February 2019 - The Pharmacy Guild of Australia wants to see more affordable medicines for all Australians, and the ...

Read more →

Rebates to the dustbin of history?

4 February 2019 - The Trump Administration has proposed eliminating certain rebates drug manufacturers pay pharmacy benefit managers and insurers.  ...

Read more →